Comparison of antibody responses of heterologous and homologous Covid-19 booster vaccination: an observational study
The administration of a third dosage of Pfizer BNT162b2 after two doses of BBIBP-CorV is recommended to boost the humoral immune response in the general population while there was no gender-specific difference observed. More effectiveness can be attained by administering additional doses due to the antibody decay.
Authors
- Nayab Batool Rizvi (ORCID: https://orcid.org/0000-0003-3815-2344)
- Majeed Rana (ORCID: https://orcid.org/0000-0003-0993-5067)
- Maryam Bibi (ORCID: https://orcid.org/0009-0006-5165-6888)
- Sehrish Zaffar (ORCID: https://orcid.org/0000-0002-1234-3807)
- Hassam Farooq
Institutions
- University of the Punjab (PK)
- Combined Military Hospital (PK)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-11-13
- DOI
- https://doi.org/10.3389/fimmu.2024.1448408
- Citations
- 3
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 1.17